Mizner Bioscience, LLC., announced that they received the first US FDA approval for a therapeutically equivalent generic version of Elanco’s Clomicalm®, Approved by the U.S. Food and Drug Administration through the Abbreviated New Animal Drug Application pathway.
October 30, 2019
· 1 min read